ADIL
$0.28
Adial Pharmaceuticals
$.01
3.89%
ADIL
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  ($0.06)
Revenue:  N/A
Friday
Aug 11
8:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ADIL reports earnings?
Beat
Meet
Miss

Where is ADIL's stock price going from here?
Up
Flat
Down
Stock chart of ADIL
Analysts
Summary of analysts' recommendations for ADIL
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focused on the development of a therapeutic agent for the treatment of alcohol use disorder. The company's lead product consists of AD04 which is in clinical stage. Adial Pharmaceuticals Inc. is based in CHARLOTTESVILLE.
›